DermTech, Inc. Common Stock
DMTK
DMTK was delisted on the 26th of June, 2024.
151 hedge funds and large institutions have $322M invested in DermTech, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 43 increasing their positions, 43 reducing their positions, and 26 closing their positions.
300% more funds holding in top 10
Funds holding in top 10: 1 → 4 (+3)
35% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 26
6% more funds holding
Funds holding: 143 → 151 (+8)
0% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 43
8% less capital invested
Capital invested by funds: $351M → $322M (-$29.1M)
21% less call options, than puts
Call options by funds: $3.52M | Put options by funds: $4.43M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
+$11.1M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$6.4M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
+$5.74M |
| 4 |
Morgan Stanley
New York
|
+$3.08M |
| 5 |
State Street
Boston,
Massachusetts
|
+$3.02M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$17.4M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$9.73M |
| 3 |
CG
Carmignac Gestion
Paris,
France
|
-$9.31M |
| 4 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
-$4.24M |
| 5 |
SM
Senvest Management
New York
|
-$3.97M |
DMTK Hedge Fund Activity: Q1 2022 in Review
151 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Common Stock (DMTK) for Q1 2022, worth a combined $322M — down 8.3% from $351M a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new DMTK positions and 26 closed out — a net gain of 9 holders — while 43 added to existing stakes and 43 trimmed.
The largest buyer was Invenomic Capital Management, adding an estimated $11.1M. The largest seller was UBS O'Connor, exiting entirely with an estimated $17.4M sold.
- 151 institutional investors held DermTech, Inc. Common Stock (DMTK) as of Q1 2022, up from 143 in Q4 2021.
- Funds reported $322M of DermTech, Inc. Common Stock stock for Q1 2022, down 8.3% quarter-over-quarter.
- 35 funds opened new DermTech, Inc. Common Stock positions in Q1 2022 and 26 closed out, a net change of +9 holders.
- The largest DermTech, Inc. Common Stock buyer in Q1 2022 was Invenomic Capital Management, an estimated $11.1M added.
- The largest DermTech, Inc. Common Stock seller in Q1 2022 was UBS O'Connor, an estimated $17.4M sold.
Based on aggregated 13F filings for Q1 2022.